
Our coolest superpower: Seeing all the atoms
Wouldn't it be great if we could just see all the atoms of all the molecules, any time we wanted?
If we were able to sample something — anything — and just tell what it's made of? Where all its atoms were? Which ones were connected or ready to react?
In about the span of a century, scientists have learned more about molecules and their components than we ever thought possible. In some cases, we can already pick up a bit of dust or a tiny droplet and see where the atoms of its resident molecules are. Or we can calculate predicted structures that are so accurate they can be used to predict function.
In old comic books, this kind of X-ray vision was the stuff of superheroes. Someday, in the not-too-distant future, we might all have it.
Submit an abstract
Abstract submission begins Sept. 14. If you submit by Oct. 12, you'll get a decision by Nov. 1. The regular submission deadline is Nov. 30. See the categories.
Join us for a glimpse into the challenges and opportunities of building that future, so we can all scrutinize, predict, build, target and react to all the molecules.
Keywords: Structure, cryo-electron microscopy, microcrystal electron diffraction, alpha fold, tomography, artificial intelligence.
Who should attend: Absolutely everyone should attend. Who doesn't want a superpower?
Theme song: “Mosaic” by Art Blakey and the Jazz Messengers
This session is literally powered by electrons and photons.
New frontiers in structural biology
The rise of molecular assemblies

Chair: Rebecca Vorhees
Sarah Shahmoradian, University of Texas Southwestern Medical Center
Lorena Saelices, University of Texas Southwestern Medical Center
New approaches enabling structural science
Chair: Jose Rodriguez
Roger Castells–Graells, University of California, Los Angeles
Hosea Nelson, California Institute of Technology
Hong Zhou, University of California, Los Angeles
Seeing the chemistry of life
Chair: Hosea Nelson
Lindsey R. F. Backman, Whitehead Institute for Biomedical Research
Douglas Rees, California Institute of Technology
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we’ll send you a weekly email with recent articles, interviews and more.
Latest in Science
Science highlights or most popular articles

Training AI to uncover novel antimicrobials
Antibiotic resistance kills millions, but César de la Fuente’s lab is fighting back. By pairing AI with human insight, researchers are uncovering hidden antimicrobial peptides across the tree of life with a 93% success rate against deadly pathogens.

AI-designed biomarker improves malaria diagnostics
Researchers from the University of Melbourne engineered Plasmodium vivax diagnostic protein with enhanced yield and stability while preserving antibody-binding, paving the way for more reliable malaria testing.

Matrix metalloproteinase inhibitor reduces cancer invasion
Scientists at the Mayo Clinic engineered a TIMP-1 protein variant that selectively inhibits MMP-9 and reduces invasion of triple-negative breast cancer cells, offering a promising tool for targeted cancer research.

Antibiotic sensor directly binds drug in resistant bacteria
Researchers at Drexel University uncover how the vancomycin-resistant bacterial sensor binds to the antibiotic, offering insights to guide inhibitor design that restores antibiotic effectiveness against hospital-acquired infections.

ApoA1 reduce atherosclerotic plaques via cell death pathway
Researchers show that ApoA1, a key HDL protein, helps reduce plaque and necrotic core formation in atherosclerosis by modulating Bim-driven macrophage death. The findings reveal new insights into how ApoA1 protects against heart disease.

Omega-3 lowers inflammation, blood pressure in obese adults
A randomized study shows omega-3 supplements reduce proinflammatory chemokines and lower blood pressure in obese adults, furthering the understanding of how to modulate cardiovascular disease risk.